Abstract:Background Prenatal adverse environments can cause fetal intrauterine growth retardation (IUGR) and higher susceptibility to multiple diseases after birth, related to multi-organ development programming changes mediated by intrauterine overexposure to maternal glucocorticoids. As a glucocorticoid barrier, P-glycoprotein (P-gp) is highly expressed in placental syncytiotrophoblasts; however, the effect of P-gp on the occurrence of IUGR remains unclear. Methods Human placenta and fetal cord blood samples of IUGR fetuses were collected, and the related indexes were detected. Pregnant Wistar rats were administered with 30 mg/kg center dot d (low dose) and 120 mg/kg center dot d (high dose) caffeine from gestational day (GD) 9 to 20 to construct the rat IUGR model. Pregnant mice were administered with caffeine (120 mg/kg center dot d) separately or combined with sodium ferulate (50 mg/kg center dot d) from gestational day GD 9 to 18 to confirm the intervention target on fetal weight loss caused by prenatal caffeine exposure (PCE). The fetal serum/placental corticosterone level, placental P-gp expression, and related indicator changes were analyzed. In vitro, primary human trophoblasts and BeWo cells were used to confirm the effect of caffeine on P-gp and its mechanism. Results The placental P-gp expression was significantly reduced, but the umbilical cord blood cortisol level was increased in clinical samples of the IUGR neonates, which were positively and negatively correlated with the neonatal birth weight, respectively. Meanwhile, in the PCE-induced IUGR rat model, the placental P-gp expression of IUGR rats was decreased while the corticosterone levels of the placentas/fetal blood were increased, which were positively and negatively correlated with the decreased placental/fetal weights, respectively. Combined with the PCE-induced IUGR rat model, in vitro caffeine-treated placental trophoblasts, we confirmed that caffeine decreased the histone acetylation and expression of P-gp via RYR/JNK/YB-1/P300 pathway, which inhibited placental and fetal development. We further demonstrated that P-gp inducer sodium ferulate could reverse the inhibitory effect of caffeine on the fetal body/placental weight. Finally, clinical specimens and other animal models of IUGR also confirmed that the JNK/YB-1 pathway is a co-regulatory mechanism of P-gp expression inhibition, among which the expression of YB-1 is the most stable. Therefore, we proposed that YB-1 could be used as the potential early warning target for the opening of the placental glucocorticoid barrier, the occurrence of IUGR, and the susceptibility of a variety of diseases. Conclusions This study, for the first time, clarified the critical role and epigenetic regulation mechanism of P-gp in mediating the opening mechanism of the placental glucocorticoid barrier, providing a novel idea for exploring the early warning, prevention, and treatment strategies of IUGR.

Prenatal Caffeine Exposure Induces Liver Developmental Dysfunction in Offspring Rats.

Prenatal Caffeine Exposure Increases the Susceptibility to Non-Alcoholic Fatty Liver Disease in Female Offspring Rats Via Activation of GR-C/EBPα-SIRT1 Pathway.

Intrauterine Endogenous High Glucocorticoids Program Ovarian Dysfunction in Female Offspring Secondary to Prenatal Caffeine Exposure

Intrauterine Metabolic Programming Alteration Increased Susceptibility to Non-Alcoholic Adult Fatty Liver Disease in Prenatal Caffeine-Exposed Rat Offspring

IGF1/MAPK/ERK signaling pathway-mediated programming alterations of adrenal cortex cell proliferation by prenatal caffeine exposure in male offspring rats

Effects of Prenatal Caffeine Exposure on Glucose Homeostasis of Adult Offspring Rats

Intrauterine Programming of Glucocorticoid–Insulin-Like Growth Factor-1 Axis–Mediated Developmental Origin of Osteoporosis Susceptibility in Female Offspring Rats with Prenatal Caffeine Exposure

Intrauterine Programming Mechanism for Hypercholesterolemia in Prenatal Caffeine-Exposed Female Adult Rat Offspring.

The GC-IGF1 axis-mediated testicular dysplasia caused by prenatal caffeine exposure.

Glucocorticoid Mediates Prenatal Caffeine Exposure-Induced Endochondral Ossification Retardation and Its Molecular Mechanism in Female Fetal Rats

Glucocorticoid-insulin-like Growth Factor 1 (GC-IGF1) Axis Programming Mediated Hepatic Lipid-Metabolic in Offspring Caused by Prenatal Ethanol Exposure.

Caffeine-induced Fetal Rat Over-Exposure to Maternal Glucocorticoid and Histone Methylation of Liver IGF-1 Might Cause Skeletal Growth Retardation.

Prenatal caffeine exposure induced renal developmental toxicity and transgenerational effect in rat offspring

Maternal Glucocorticoid Elevation and Associated Blood Metabonome Changes Might Be Involved in Metabolic Programming of Intrauterine Growth Retardation in Rats Exposed to Caffeine Prenatally

High-fat Diet and Chronic Stress Aggravate Adrenal Function Abnormality Induced by Prenatal Caffeine Exposure in Male Offspring Rats

Prenatal Caffeine Exposure Induced High Susceptibility to Metabolic Syndrome in Adult Female Offspring Rats and Its Underlying Mechanisms.

Caffeine programs hepatic SIRT1-related cholesterol synthesis and hypercholesterolemia via A2AR/cAMP/PKA pathway in adult male offspring rats.

Prenatal Ethanol Exposure Programs an Increased Susceptibility of Non-Alcoholic Fatty Liver Disease in Female Adult Offspring Rats

Prenatal caffeine ingestion induces transgenerational neuroendocrine metabolic programming alteration in second generation rats

Correction To: P-gp Expression Inhibition Mediates Placental Glucocorticoid Barrier Opening and Fetal Weight Loss.

Effects of Prenatal Nicotine Exposure on Hepatic Glucose and Lipid Metabolism in Offspring Rats and Its Hereditability.